In the News

Targeting cancer cells: Two studies take different approaches

6/26/2024

A study designed to treat recurrent epithelial ovarian cancer looks at an antibody drug conjugate, and a second study for people with advanced breast cancer evaluates a drug that degrades estrogen rec

The evolution of cancer immunotherapy: Dr. Urba shares his insights

6/28/2024

Providence Cancer Institute chief medical officer Walter J. Urba, M.D., Ph.D. talks about the evolution of immunotherapy in the past three decades and his vision for its future.

Cancer survivorship: A guide to living with and beyond cancer

6/11/2024

June is National Cancer Survivor Month, but we honor people with cancer, no matter where they are on their journey, every day of the year. Find out about the survivorship program at Providence Cancer

Attend free virtual event on MRI-guided radiation therapy for pancreatic cancer

6/4/2024

Providence Cancer Institute presents a free virtual education event about MRI-guided radiation therapy and how it is used to treat pancreatic cancer.

Providence researchers contribute study findings at ASCO 2024 meeting, May 31- June 3

6/10/2024

The annual meeting of cancer experts is a platform to collaborate and accelerate cancer research findings into clinical applications.

With the potential to transform cancer diagnostics, Providence contributes to innovative AI-powered digital pathology model

6/3/2024

A joint study between Providence, Microsoft and the University of Washington detailing work to create a novel AI-powered pathology model has been published in Nature.

2023 research report highlights breadth and impact of research at Providence

5/20/2024

Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report

Cancer studies seek to harness the power of the immune system

5/29/2024

Explore three innovative studies targeting uveal melanoma, melanoma and head and neck squamous cell carcinoma. Learn why these studies offer hope for more effective cancer treatments.

Celebrating World Immunology Day

4/26/2024

Providence Cancer Institute researcher shares her journey to immunology and the advice she has for those seeking a career in cancer research.

New vaccine being studied for HPV+ head and neck cancer

5/7/2024

Researchers at Providence Cancer Institute are exploring a range of innovative approaches to targeting human papillomavirus-positive head and neck squamous cell cancer.

Looking ahead: Growth and advancements in surgical oncology at Providence Cancer Institute

4/3/2024

Growing the surgical oncology programs at Providence Cancer Institute is a testament to our commitment to providing research-focused, comprehensive services and improving outcomes for patients.

Celebrating our oncology social workers

3/25/2024

In recognition of National Social Work Month, Darlene Corral, LCSW, shares a little insight into the importance of oncology social workers.

Talking to an expert: The crucial role of nutrition in cancer care

3/19/2024

In honor of National Nutrition Month® Alyssa George, MA, RDN, program manager at Oncology Nutrition, Providence Cancer Institute, talks about the important connection between cancer and nutrition.

How promoting apoptosis in new study may help people with cancer

3/21/2024

In a new clinical trial open at Providence Cancer Institute, the therapy IGM-8444 aims to promote apoptosis, potentially slowing down the growth of DR5-positive tumor cells.

Dose-escalation studies aspire to fill gaps in cancer treatment options

2/26/2024

Two early phase trials available at Providence Cancer Institute to evaluate escalating doses of different potential cancer treatments in patients with advanced solid tumors.

FDA approves cellular therapy, offering hope to more people with cancer

3/6/2024

The Food and Drug Administration has approved an adoptive cell therapy for adult patients with melanoma that has spread to other parts of the body (metastatic).

Providence oncology nurse practitioner receives Values in Action Award

2/12/2024

Jamie Zilverberg, MSN, FNP, AOCNP, receives the prestigious 2024 Values in Action Award, the highest honor given at Providence St. Joseph Health.

Celebrating Women in Science

5/3/2024

In honor of International Day of Women and Girls in Science we highlight a researcher at Earle A. Chiles Research Institute, the research arm of Providence Cancer Institute.

Virtual education: Food and common cancer myths

3/14/2024

Providence registered dietitian Christina Speaks, MS, RDN, LD, shares valuable information about food and common cancer myths.

Studies address need for more treatment options in endometrial cancer and AML

1/24/2024

New study evaluates immunotherapy in combination with other medications in people with endometrial cancer, and a phase I trial for people with AML assesses a non-engineered natural killer cell therapy

Emmy-nominated film features Providence patients, researchers in pursuit of revolutionary cancer therapy

6/26/2024

"Within Reach: The Fight to Finish Cancer" follows patient participants and teams of researchers and clinicians at Providence Cancer Institute working to create a living drug for incurable cancers.

Promising results of amivantamab studies appear in high-profile journals

3/13/2024

New articles co-authored by Dr. Rachel Sanborn feature amivantamab studies for people with NSCLC.

A remarkable year of engagement and advancements at Providence Cancer Institute

1/10/2024

Highlights from 2023 events, achievements and advancements at Providence Cancer Institute.

Meet Dr. Anderson: At home in Hood River, on a trail, beach or mountaintop

12/13/2023

Providence hematology oncologist and outdoors enthusiast Eric C. Anderson, M.D., shares his love of the Pacific Northwest and his philosophy of care for patients.

Immunotherapies for GI and lung cancers evaluated in new studies

11/20/2023

A study for people with GI cancers and two studies for people with advanced and early-stage lung cancer hope to develop better treatment options with the help of immunotherapy.

Genomic testing can improve outcomes for people with advanced cancer, study shows

11/3/2023

Providence researchers say comprehensive genomic profiling can be pivotal in identifying gene mutations in a patient and tailoring personalized treatment strategies.

Providence researchers contribute to 21 studies at SITC2023

11/20/2023

SITC 2023 provides a glimpse into scientific advances and breakthroughs in cancer immunotherapy by researchers from around the world.

Watch a free virtual talk on lung cancer prevention and treatment

Providence Cancer Institute lung cancer expert to present a virtual education talk on lung cancer screening, prevention and latest treatments.

New studies address unmet needs in treating triple-negative breast cancer

10/12/2023

Two new studies available at Earle A. Chiles Research Institute, at division of Providence Cancer Institute of Oregon, to evaluate new treatments for triple-negative breast cancer.

Dr. Urba receives award for his contributions to science and community

10/4/2023

Providence Cancer Institute of Oregon, and research director, Earle A. Chiles Research Institute, Walter J. Urba, M.D., Ph.D., receives award for his contributions to science and community.